Ligand Pharmaceuticals (LGND) EBITDA (2010 - 2026)
Ligand Pharmaceuticals' EBITDA came in at $16.81 million for Q2 2026, down 0.9% from $16.97 million a year earlier and down 34.3% from the prior quarter.
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) EBITDA (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Ligand Pharmaceuticals reported EBITDA of $127.65 million; for FY2025, it was $74.78 million, up 491.9% from FY2024.
- EBITDA carries a five-year compound annual growth rate of 3.4% (FY2020 to FY2025).
- Going back by year, EBITDA was $12.63 million in FY2024 (-73.9%), $48.46 million in FY2023 (-11.2%), $54.57 million in FY2022 (-64.8%) and $154.92 million in FY2021 (+145.2%).
- The Q2 2026 figure represents the lowest quarterly EBITDA since Q1 2025.
- The fastest year-over-year change in EBITDA over five years came in Q3 2025 (growth of 420.7%), and the weakest in Q2 2023 (a decline of 65.7%).
- Business Quant data shows LGND's EBITDA at $25.58 million (Q1 2026), $22.06 million (Q4 2025) and $63.2 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Ligand Pharmaceuticals | 6.15 Bn | 2.61 Bn | - | 17.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.63 Mn |
| Mar 31, 2026 | 26.39 Mn |
| Dec 31, 2025 | 22.62 Mn |
| Sep 30, 2025 | 63.65 Mn |
| Jun 30, 2025 | 17.09 Mn |
| Mar 31, 2025 | -27.31 Mn |
| Dec 31, 2024 | -838,000.00 |
| Sep 30, 2024 | 12.27 Mn |
| Jun 30, 2024 | -10.15 Mn |
| Mar 31, 2024 | 11.84 Mn |
| Dec 31, 2023 | 5.64 Mn |
| Sep 30, 2023 | 11.69 Mn |
| Jun 30, 2023 | 7.58 Mn |
| Mar 31, 2023 | 23.80 Mn |
| Dec 31, 2022 | -8.87 Mn |
| Sep 30, 2022 | 25.96 Mn |
| Jun 30, 2022 | 22.10 Mn |
| Mar 31, 2022 | 16.11 Mn |
| Dec 31, 2021 | 54.69 Mn |
| Sep 30, 2021 | 32.22 Mn |
API Access
Ligand Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=LGND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();